The gaitQ® team was selected to participate in the Oxford Academic Health Science Network (AHSN) Accelerator programme, delivered by Biocity. This programme is designed to help innovators transition their project from academia into a comercially-viable spin-out. Through conversations with stakeholders and mentors, both from business and NHS, the team pinpointed the value proposition for their gait-freezing solution and developed the work plan to bring it to market. Ultimately, a board of selected investors and NHS directors awarded gaitQ® with the Best Project accolade.